Related Experiment Video
Updated: Jul 15, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Changes in red cell phosphate metabolism of preterm and fullterm infants with perinatal problems during their first
V Cholevas1, A Challa, P D Lapatsanis
1Research Laboratory of Child Health Department, University of Ioannina, Medical School, P.O. Box 1186, Ioannina, 451 10, Greece. bcholev@cc.uoi.gr
Insights
Perinatal issues significantly delay phosphate metabolism in preterm infants, affecting red cell 2,3-DPG levels. Fullterm infants show different metabolic responses to these challenges.
Area of Science:
- Neonatal physiology
- Biochemistry
- Perinatal medicine
Background:
- Perinatal problems can impact infant metabolism.
- Red blood cell (RBC) phosphate metabolism is crucial for oxygen delivery.
Purpose of the Study:
- To investigate the effects of perinatal problems on red cell phosphate metabolism in preterm and fullterm infants during the first month of life.
Main Methods:
- Comparison of plasma and RBC inorganic phosphate (Pi), 2,3-diphosphoglycerate (2,3-DPG), and ATP levels.
- Study included two groups of infants: preterms and fullterms, each with and without perinatal problems.
- Measurements were taken throughout the first month of life.
Main Results:
- Preterm infants with perinatal problems showed delayed recovery of plasma and RBC Pi, and lower erythrocyte 2,3-DPG compared to controls.
- Fullterm infants with perinatal problems had lower RBC Pi and ATP, but no significant difference in plasma Pi or RBC 2,3-DPG.
- Fullterm infants with problems had higher plasma and RBC Pi than affected preterms.
- RBC 2,3-DPG correlated with Pi levels in preterms and sick fullterms, but only with RBC Pi in healthy fullterms.
Conclusions:
- Perinatal problems differentially affect phosphate metabolism in preterm and fullterm neonates.
- These metabolic alterations may have implications for oxygen transport in vulnerable infants.
Abstract:
The effects of perinatal problems on red cell phosphate metabolism were studied in two groups of infants (preterms B and fullterms D) during the first month of life. All infants started milk feeding from day three after birth. The results were compared to those of healthy preterms (A) and fullterms (C), respectively. Comparisons were also made between the preterm and fullterm groups B and D. The preterms with perinatal problems (B) showed a significant delay in catching up with the plasma and red cell inorganic phosphate (Pi) levels of controls (A) throughout the first month of life (p < 0.05). In parallel, the erythrocyte 2,3 diphosphoglycerate (2,3-DPG) concentrations of the sick preterms lagged significantly behind those of controls (p < 0.001); but the ATP levels were comparable between the two groups. The fullterms behaved slightly differently. No significant differences in plasma Pi (Pl Pi) and red cell 2,3-DPG were seen between the sick and healthy neonates during the month of study, while red cell Pi (RBC Pi) and ATP were found to be lower in the sick ones (p < 0.05). The fullterms with perinatal problems (D) had significantly higher Pl Pi (p < 0.05) and RBC Pi (p < 0.01) than preterms with problems (B) from the first week of life and continued in a similar pattern until the end of the month. Red cell 2,3-DPG concentrations were found to be significantly correlated with Pl Pi and RBC Pi in both preterm groups (p < 0.01) and in the sick fullterms (p < 0.001) during the time of the study. In the healthy fullterms 2,3-DPG was found to correlate only with red cell Pi (p < 0.05). Perinatal problems seem to affect Pi metabolism to a different degree in preterm and fullterm neonates in the first month of life.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Erythropoiesis
